These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1003412)

  • 1. Some novel potential alkylating agents derived from diethylstilbestrol.
    Roushdi IM; Omar AM; Ragab MS; Awad M
    J Med Chem; 1976 Nov; 19(11):1333-6. PubMed ID: 1003412
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of cross-resistance to alkylating agents in cyclophosphamide-resistant L1210 leukemia.
    Wampler GL; Regelson W; Bardos TJ
    Eur J Cancer (1965); 1978 Sep; 14(9):977-82. PubMed ID: 710488
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and pharmacological screening of 1-chloro-3-(2-propynyloxy)-2-propanols and 2-((2-propynyloxy)methyl)oxiranes.
    Fugitt RB; Wu GS; Martinelli LC
    J Pharm Sci; 1973 Nov; 62(11):1894-6. PubMed ID: 4758098
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential bis-alkylating agents for cancer chemotherapy. Approaches to the synthesis of 2-sulfonyl-1,4-bis(methanesulfonoxy)butanes.
    Wilbur JM
    J Med Chem; 1978 Nov; 21(11):1168-71. PubMed ID: 214556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.
    Takamizawa A; Matsumoto S; Iwata T; Makino I; Yamaguchi K; Uchida N; Kasai H; Shiratori O; Takase S
    J Med Chem; 1978 Feb; 21(2):208-14. PubMed ID: 621716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
    Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
    J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Wheeler GP; Adamson DJ; Webster J
    Cancer Res; 1985 Jul; 45(7):3400-2. PubMed ID: 4005864
    [No Abstract]   [Full Text] [Related]  

  • 9. Liposomal potentiation of the antitumor activity of alkylating drugs.
    Rutman RJ; Ritter CA; Avadhani NG; Hansel J
    Cancer Treat Rep; 1976 May; 60(5):617-8. PubMed ID: 991151
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor and antileukemic effects of some steroids and other biologically interesting compounds containing an alkylating agent.
    Carroll FI; Philip A; Blackwell JT; Taylor DJ; Wall ME
    J Med Chem; 1972 Nov; 15(11):1158-61. PubMed ID: 4654665
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoquinolines. 6. Potential central nervous system antitumor agents. Nitrogen mustards of 3-amino-4-(p-aminophenyl)isoquinoline.
    Filer CN; Granchelli FE; Soloway AH; Neumeyer JL
    J Med Chem; 1977 Nov; 20(11):1504-8. PubMed ID: 915914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents.
    Hsiao YY; Bardos TJ; Wampler GL; Regelson W
    J Med Chem; 1975 Feb; 18(2):195-8. PubMed ID: 1120987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of novel hexestrol and diethylstilbestrol derivatives as potential anticancer and estrogenic agents.
    Ibrahim ES; Omar AM; Khalil MA; Makar MA; Soliman MT; Daabees TT
    Pharmazie; 1980 Feb; 35(2):80-4. PubMed ID: 6247720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2-bis(arylsulfonyl)hydrazines. 2. The influence of arylsulfonyl and aralkylsulfonyl substituents on antitumor and alkylating activity.
    Shyam K; Furubayashi R; Hrubiec RT; Cosby LA; Sartorelli AC
    J Med Chem; 1986 Jul; 29(7):1323-5. PubMed ID: 3806585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives.
    Lin AJ; Cosby LA; Shansky CW; Sartorelli AC
    J Med Chem; 1972 Dec; 15(12):1247-52. PubMed ID: 4635968
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential bioreductive alkylating agents. 3. Synthesis and antineoplastic activity of acetoxymethyl and corresponding ethyl carbamate derivatives of benzoquinones.
    Lin AJ; Shansky CW; Sartorelli AC
    J Med Chem; 1974 May; 17(5):558-61. PubMed ID: 4830263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.